Chanchal Goswami

3.6k total citations
21 papers, 563 citations indexed

About

Chanchal Goswami is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Chanchal Goswami has authored 21 papers receiving a total of 563 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 3 papers in Surgery. Recurrent topics in Chanchal Goswami's work include Colorectal Cancer Treatments and Studies (7 papers), Lung Cancer Treatments and Mutations (6 papers) and HER2/EGFR in Cancer Research (5 papers). Chanchal Goswami is often cited by papers focused on Colorectal Cancer Treatments and Studies (7 papers), Lung Cancer Treatments and Mutations (6 papers) and HER2/EGFR in Cancer Research (5 papers). Chanchal Goswami collaborates with scholars based in India, United States and Spain. Chanchal Goswami's co-authors include Suresh H. Advani, Rajendra Badwe, Alvin Wong, Lisa A. Carey, Ron Bose, Richard Bryce, Suryanarayan V.S. Deo, Thomas Bachelot, Kenichi Inoue and Ajay Mehta and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and Annals of Oncology.

In The Last Decade

Chanchal Goswami

19 papers receiving 545 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chanchal Goswami India 11 395 297 91 75 71 21 563
Marcello Ferretti Fanelli Brazil 16 410 1.0× 305 1.0× 30 0.3× 119 1.6× 76 1.1× 47 697
Shu-Fang Hsu Schmitz Switzerland 6 287 0.7× 345 1.2× 29 0.3× 35 0.5× 83 1.2× 9 577
Ewa Chmielowska Poland 12 251 0.6× 132 0.4× 70 0.8× 109 1.5× 26 0.4× 44 468
J.M. del Campo Spain 10 373 0.9× 217 0.7× 53 0.6× 211 2.8× 19 0.3× 17 639
Berna Akkuş Yıldırım Türkiye 13 177 0.4× 183 0.6× 57 0.6× 20 0.3× 41 0.6× 64 484
Emi Noguchi Japan 12 352 0.9× 208 0.7× 24 0.3× 115 1.5× 41 0.6× 63 608
Ha Young Woo South Korea 12 118 0.3× 134 0.5× 108 1.2× 77 1.0× 28 0.4× 34 531
Véronique Lorgis France 13 272 0.7× 215 0.7× 24 0.3× 63 0.8× 144 2.0× 39 572
H. S. Hochster United States 12 430 1.1× 130 0.4× 20 0.2× 79 1.1× 62 0.9× 21 517
Amy Sheen Australia 15 247 0.6× 250 0.8× 18 0.2× 116 1.5× 41 0.6× 30 627

Countries citing papers authored by Chanchal Goswami

Since Specialization
Citations

This map shows the geographic impact of Chanchal Goswami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chanchal Goswami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chanchal Goswami more than expected).

Fields of papers citing papers by Chanchal Goswami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chanchal Goswami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chanchal Goswami. The network helps show where Chanchal Goswami may publish in the future.

Co-authorship network of co-authors of Chanchal Goswami

This figure shows the co-authorship network connecting the top 25 collaborators of Chanchal Goswami. A scholar is included among the top collaborators of Chanchal Goswami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chanchal Goswami. Chanchal Goswami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gupta, Sudeep, Senthil Rajappa, Suresh H. Advani, et al.. (2021). Prevalence of BRCA1 and BRCA2 Mutations Among Patients With Ovarian, Primary Peritoneal, and Fallopian Tube Cancer in India: A Multicenter Cross-Sectional Study. JCO Global Oncology. 7(7). 849–861. 22 indexed citations
2.
Vaid, Ashok K., Hemant Malhotra, Reena Nair, et al.. (2021). Indian Expert Opinion on Cancer Care during COVID-19 Pandemic. South Asian Journal of Cancer. 10(1). 9–18.
3.
Vaid, Ashok K., Sudeep Gupta, Dinesh Doval, et al.. (2020). Expert Consensus on Effective Management of Chemotherapy-Induced Nausea and Vomiting: An Indian Perspective. Frontiers in Oncology. 10. 400–400. 10 indexed citations
4.
5.
Gupta, Sudeep, Suresh H. Advani, Amit Agarwal, et al.. (2019). A non-interventional, multicenter study to assess prevalence of BRCA1 and BRCA2 mutation among ovarian, primary peritoneal, and fallopian tube cancer patients in India.. Journal of Clinical Oncology. 37(15_suppl). e13073–e13073.
6.
Goswami, Chanchal, et al.. (2019). Role of molecular diagnostics in determination of tissue of origin in Cancer of Unknown Primary (CUP). 4. 50–55. 1 indexed citations
7.
Muro, Kei, Y. Choi, G. Bodoky, et al.. (2017). Efficacy and safety of ramucirumab (RAM) for metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma across age subgroups in two global phase 3 trials.. Journal of Clinical Oncology. 35(4_suppl). 3–3. 3 indexed citations
8.
Advani, Suresh H., Hemant Malhotra, Raju Titus Chacko, et al.. (2017). Advanced therapeutic options and importance of rebiopsy in epidermal growth factor receptor-tyrosine kinase inhibitor-progressed nonsmall cell lung carcinoma patients: An expert opinion. Indian Journal of Cancer. 54(5). 31–31. 1 indexed citations
9.
Muro, Kei, Y. Choi, G. Bodoky, et al.. (2017). Age does not influence efficacy of ramucirumab in advanced gastric cancer: Subgroup analyses of REGARD and RAINBOW. Journal of Gastroenterology and Hepatology. 33(4). 814–824. 16 indexed citations
10.
Awada, Ahmad, Rámón Colomer, Kenichi Inoue, et al.. (2016). Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer. JAMA Oncology. 2(12). 1557–1557. 217 indexed citations
11.
Awada, Ahmad, Rámón Colomer, Igor Bondarenko, et al.. (2015). Efficacy and CNS progression analysis from the randomized phase 2 trial of neratinib + paclitaxel vs trastuzumab + paclitaxel as first-line treatment for HER2+ metastatic breast cancer (NEfERTT).. Journal of Clinical Oncology. 33(15_suppl). 610–610. 7 indexed citations
12.
Gupta, Sanjay, Dinesh Chandra Doval, Kumar Prabhash, et al.. (2015). Clinical and epidemiological study of EGFR mutations and EML4-ALK fusion genes among Indian patients with adenocarcinoma of the lung. OncoTargets and Therapy. 8. 117–117. 38 indexed citations
13.
Babu, Govind K, Ashok K. Vaid, Bhawna Sirohi, et al.. (2014). Nimotuzumab plus chemotherapy versus chemotherapy alone in advanced non-small-cell lung cancer: a multicenter, randomized, open-label Phase II study. OncoTargets and Therapy. 7. 1051–1051. 22 indexed citations
14.
15.
Tabernero, Josep, Jiří Tomášek, Rodolfo Passalacqua, et al.. (2013). Regard Phase 3, Randomized Trial of Ramucirumab in Patients with Metastatic Gastric or Gej Adenocarcinoma Following Progression on First-Line Chemotherapy. Annals of Oncology. 24. iv14–iv14. 2 indexed citations
16.
Digumarti, Raghunadharao, Reena Nair, Dinesh Bhurani, et al.. (2013). Histopathological pattern of lymphomas and clinical presentation and outcomes of diffuse large B cell lymphoma: A multicenter registry based study from India. Indian Journal of Medical and Paediatric Oncology. 34(4). 299–304. 21 indexed citations
17.
Prabhash, Kumar, Ashok K. Vaid, Bhawna Sirohi, et al.. (2013). Nimotuzumab plus chemotherapy versus chemotherapy alone in advanced non-small cell lung cancer: A phase II, open-label, multicenter, randomized study.. Journal of Clinical Oncology. 31(15_suppl). 8053–8053. 2 indexed citations
18.
Ranade, Anantbhushan, P. P. Bapsy, Shona Nag, et al.. (2012). A multicenter phase II randomized study of Cremophor‐free polymeric nanoparticle formulation of paclitaxel in women with locally advanced and/or metastatic breast cancer after failure of anthracycline. Asia-Pacific Journal of Clinical Oncology. 9(2). 176–181. 15 indexed citations
19.
Gotlieb, Walter H., Frédéric Amant, Suresh H. Advani, et al.. (2011). Intravenous aflibercept for treatment of recurrent symptomatic malignant ascites in patients with advanced ovarian cancer: a phase 2, randomised, double-blind, placebo-controlled study. The Lancet Oncology. 13(2). 154–162. 119 indexed citations
20.
Goswami, Chanchal, et al.. (2007). Post-irradiation angiosarcoma of bone. Journal of Cancer Research and Therapeutics. 3(2). 96–96. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marcello Ferretti Fanelli Breakdown of academic impact, for papers by Shu-Fang Hsu Schmitz Breakdown of academic impact, for papers by Ewa Chmielowska Breakdown of academic impact, for papers by J.M. del Campo Breakdown of academic impact, for papers by Berna Akkuş Yıldırım Breakdown of academic impact, for papers by Emi Noguchi Breakdown of academic impact, for papers by Ha Young Woo Breakdown of academic impact, for papers by Véronique Lorgis Breakdown of academic impact, for papers by H. S. Hochster Breakdown of academic impact, for papers by Amy Sheen
Rankless by CCL
2026